{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:35:31Z","timestamp":1790044531817,"version":"4.0.1"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12519-025-00972-w","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:28:42Z","timestamp":1757590122000},"page":"973-990","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Adolescent hyperandrogenism: diagnostic challenges and therapeutic approaches"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9719-1875","authenticated-orcid":false,"given":"Marcio J.","family":"Concepci\u00f3n-Zavaleta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenyfer M.","family":"Fuentes-Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca E.","family":"Zavaleta-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan Y.","family":"Arias-Cantor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Figueredo-Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia C.","family":"Coronado-Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Paz-Ibarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"972_CR1","first-page":"11","volume":"27","author":"JJ Chillar\u00f3n","year":"2020","unstructured":"Chillar\u00f3n JJ. Hirsutism: diagnosis and treatment. FMC Form Med Contin Aten Primaria. 2020;27:11\u20133 (in Spanish).","journal-title":"FMC Form Med Contin Aten Primaria"},{"key":"972_CR2","first-page":"1016","volume":"103","author":"T Zhang","year":"2023","unstructured":"Zhang T, Xu Y. Exploration of the clinical pathway for etiological diagnostics of androgen excess in female. Zhonghua Yi Xue Za Zhi. 2023;103:1016\u201321 (in Chinese).","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"972_CR3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jpag.2017.04.001","volume":"30","author":"SF Witchel","year":"2017","unstructured":"Witchel SF. Congenital adrenal hyperplasia. J Pediatr Adolesc Gynecol. 2017;30:520\u201334.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"972_CR4","first-page":"7476","volume":"25","author":"L Pkhaladze","year":"2021","unstructured":"Pkhaladze L, Russo M, Unfer V, Nordio M, Basciani S, Khomasuridze A. Treatment of lean PCOS teenagers: a follow-up comparison between Myo-inositol and oral contraceptives. Eur Rev Med Pharmacol Sci. 2021;25:7476\u201385.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"972_CR5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpag.2014.05.006","volume":"28","author":"Z S\u0131klar","year":"2015","unstructured":"S\u0131klar Z, Berbero\u011flu M, \u00c7amtosun E, Kocaay P. Diagnostic characteristics and metabolic risk factors of cases with polycystic ovary syndrome during adolescence. J Pediatr Adolesc Gynecol. 2015;28:78\u201383.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"972_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17446651.2023.2299400","volume":"19","author":"K Sardana","year":"2024","unstructured":"Sardana K, Muddebihal A, Sehrawat M, Bansal P, Khurana A. An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists. Expert Rev Endocrinol Metab. 2024;19:111\u201328.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"972_CR7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1055\/s-0041-1742259","volume":"40","author":"MR Esquivel-Zuniga","year":"2022","unstructured":"Esquivel-Zuniga MR, Kirschner CK, McCartney CR, Burt Solorzano CM. Non-PCOS hyperandrogenic disorders in adolescents. Semin Reprod Med. 2022;40:42\u201352.","journal-title":"Semin Reprod Med"},{"key":"972_CR8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/humupd\/dmae028","volume":"31","author":"AD Bizuneh","year":"2025","unstructured":"Bizuneh AD, Joham AE, Teede H, Mousa A, Earnest A, Hawley JM, et al. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome: a systematic review and diagnostic meta-analysis to inform evidence-based guidelines. Hum Reprod Update. 2025;31:48\u201363.","journal-title":"Hum Reprod Update"},{"key":"972_CR9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1007\/s00105-020-04677-1","volume":"71","author":"E Makrantonaki","year":"2020","unstructured":"Makrantonaki E, Zouboulis CC. Hyperandrogenism, adrenal dysfunction, and hirsutism. Hautarzt. 2020;71:752\u201361 (in German).","journal-title":"Hautarzt"},{"key":"972_CR10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S2213-8587(23)00036-0","volume":"11","author":"T Reinehr","year":"2023","unstructured":"Reinehr T, Dieris B. New clinical practice guideline for evaluation and treatment of children and adolescents with obesity: paradigm shifts. Lancet Diabetes Endocrinol. 2023;11:222\u20133.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"972_CR11","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2021.100085","volume":"3","author":"J Bulsara","year":"2021","unstructured":"Bulsara J, Patel P, Soni A, Acharya S. A review: brief insight into polycystic ovarian syndrome. Endocr Metab Sci. 2021;3:100085.","journal-title":"Endocr Metab Sci"},{"key":"972_CR12","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/ejendo\/lvad055","volume":"188","author":"S Kiconco","year":"2023","unstructured":"Kiconco S, Earnest A, Enticott J, Hart R, Mori TA, Hickey M, et al. Normative cut-offs for polycystic ovary syndrome diagnostic features in adolescents using cluster analysis. Eur J Endocrinol. 2023;188:494\u2013502.","journal-title":"Eur J Endocrinol"},{"key":"972_CR13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1080\/09513590.2022.2083104","volume":"38","author":"P Rojewska","year":"2022","unstructured":"Rojewska P, Meczekalski B, Bala G, Luisi S, Podfigurna A. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach. Gynecol Endocrinol. 2022;38:537\u201342.","journal-title":"Gynecol Endocrinol"},{"key":"972_CR14","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1579217","volume":"16","author":"M Nowak-Cio\u0142ek","year":"2025","unstructured":"Nowak-Cio\u0142ek M, Stachowiak JJ, Krok K, Sokal J, Malczyk \u017b, Skrzy\u0144ska K, et al. Adolescent PCOS and long-term metabolic risk: insights from triglycerides to high-density lipoprotein cholesterol ratio and high-density lipoprotein cholesterol profiles. Front Endocrinol (Lausanne). 2025;16:1579217.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"972_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12916-020-01861-x","volume":"18","author":"CT Tay","year":"2020","unstructured":"Tay CT, Hart RJ, Hickey M, Moran LJ, Earnest A, Doherty DA, et al. Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood. BMC Med. 2020;18:389.","journal-title":"BMC Med"},{"key":"972_CR16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/01.JAA.0000791468.37054.5d","volume":"34","author":"JL Conlon","year":"2021","unstructured":"Conlon JL, Malcolm S, Monaghan M. Diagnosis and treatment of polycystic ovary syndrome in adolescents. JAAPA. 2021;34:15\u201322.","journal-title":"JAAPA"},{"key":"972_CR17","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jpag.2017.12.002","volume":"31","author":"S Akg\u00fcl","year":"2018","unstructured":"Akg\u00fcl S, D\u00fcz\u00e7eker Y, Kanbur N, Derman O. Do different diagnostic criteria impact polycystic ovary syndrome diagnosis for adolescents? J Pediatr Adolesc Gynecol. 2018;31:258\u201362.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"972_CR18","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","volume":"108","author":"HJ Teede","year":"2023","unstructured":"Teede HJ, Tay CT, Laven JJE, Dokras A, Moran LJ, Piltonen TT, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108:2447\u201369.","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR19","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf226","author":"R Azziz","year":"2025","unstructured":"Azziz R, Amiri M, Bril F, Joham AE, Kelestimur F, Ottey S, et al. Approach to the patient: hirsutism. J Clin Endocrinol Metab. 2025. https:\/\/doi.org\/10.1210\/clinem\/dgaf226.","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","volume":"383","author":"DP Merke","year":"2020","unstructured":"Merke DP, Auchus RJ. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med. 2020;383:1248\u201361.","journal-title":"N Engl J Med"},{"key":"972_CR21","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","volume":"401","author":"MK Auer","year":"2023","unstructured":"Auer MK, Nordenstr\u00f6m A, Lajic S, Reisch N. Congenital adrenal hyperplasia. Lancet. 2023;401:227\u201344.","journal-title":"Lancet"},{"key":"972_CR22","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"Speiser PW, Arlt W, Auchus RJ, Baskin LS, Conway GS, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2018;103:4043\u201388.","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR23","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1093\/humupd\/dmx014","volume":"23","author":"E Carmina","year":"2017","unstructured":"Carmina E, Dewailly D, Escobar-Morreale HF, Kelestimur F, Moran C, Oberfield S, et al. Non-classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency revisited: an update with a special focus on adolescent and adult women. Hum Reprod Update. 2017;23:580\u201399.","journal-title":"Hum Reprod Update"},{"key":"972_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12020-015-0656-0","volume":"50","author":"H Falhammar","year":"2015","unstructured":"Falhammar H, Nordenstr\u00f6m A. Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine. 2015;50:32\u201350.","journal-title":"Endocrine"},{"key":"972_CR25","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/JU.0000000000003644","volume":"210","author":"NE Rowe","year":"2023","unstructured":"Rowe NE, Kumar R, Schieda N, Siddiqi F, McGregor T, McAlpine K, et al. Diagnosis, management, and follow-up of the incidentally discovered adrenal mass: CUA guideline endorsed by the AUA. J Urol. 2023;210:590\u20139.","journal-title":"J Urol"},{"issue":"5 Suppl 1","key":"972_CR26","first-page":"S241","volume":"86","author":"Practice Committee of the American Society for Reproductive Medicine","year":"2006","unstructured":"Practice Committee of the American Society for Reproductive Medicine. The evaluation and treatment of androgen excess. Fertil Steril. 2006;86(5 Suppl 1):S241\u20137.","journal-title":"Fertil Steril"},{"key":"972_CR27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S. Pituitary-tumor endocrinopathies. N Engl J Med. 2020;382:937\u201350.","journal-title":"N Engl J Med"},{"key":"972_CR28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116137","volume":"223","author":"A Bavaresco","year":"2024","unstructured":"Bavaresco A, Mazzeo P, Lazzara M, Barbot M. Adipose tissue in cortisol excess: what Cushing\u2019s syndrome can teach us? Biochem Pharmacol. 2024;223:116137.","journal-title":"Biochem Pharmacol"},{"key":"972_CR29","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1055\/a-2333-1907","volume":"132","author":"HF Nowotny","year":"2024","unstructured":"Nowotny HF, Braun L, Reisch N. The landscape of androgens in Cushing\u2019s syndrome. Exp Clin Endocrinol Diabetes. 2024;132:670\u20137.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"972_CR30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EJE-22-0320","volume":"187","author":"HF Nowotny","year":"2022","unstructured":"Nowotny HF, Braun L, Vogel F, Bidlingmaier M, Reincke M, Tschaidse L, et al. 11-oxygenated C19 steroids are the predominant androgens responsible for hyperandrogenemia in Cushing\u2019s disease. Eur J Endocrinol. 2022;187:663\u201373.","journal-title":"Eur J Endocrinol"},{"key":"972_CR31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2019","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2019;502:214\u201321.","journal-title":"Clin Chim Acta"},{"key":"972_CR32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09513590.2021.2003326","volume":"38","author":"JL Hern\u00e1ndez-Jim\u00e9nez","year":"2021","unstructured":"Hern\u00e1ndez-Jim\u00e9nez JL, Barrera D, Espinoza-Sim\u00f3n E, Gonz\u00e1lez J, Ort\u00edz-Hern\u00e1ndez R, Escobar L, et al. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2021;38:2\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"972_CR33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cen.13808","volume":"89","author":"S Shorakae","year":"2018","unstructured":"Shorakae S, Ranasinha S, Abell S, Lambert G, Lambert E, De Courten B, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf). 2018;89:628\u201333.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"972_CR34","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2017-00947","volume":"102","author":"MW O\u2019Reilly","year":"2017","unstructured":"O\u2019Reilly MW, Kempegowda P, Walsh M, Taylor AE, Manolopoulos KN, Allwood JW, et al. AKR1C3-mediated adipose androgen generation drives lipotoxicity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102:3327\u201339.","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR35","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/nu12071953","volume":"12","author":"M Kazemi","year":"2020","unstructured":"Kazemi M, Jarrett BY, Vanden Brink H, Lin AW, Hoeger KM, Spandorfer SD, et al. Obesity, insulin resistance, and hyperandrogenism mediate the link between poor diet quality and ovarian dysmorphology in reproductive-aged women. Nutrients. 2020;12:1953.","journal-title":"Nutrients"},{"key":"972_CR36","doi-asserted-by":"crossref","first-page":"9818","DOI":"10.3390\/ijms24129818","volume":"24","author":"D Szukiewicz","year":"2023","unstructured":"Szukiewicz D. Molecular mechanisms for the vicious cycle between insulin resistance and the inflammatory response in obesity. Int J Mol Sci. 2023;24:9818.","journal-title":"Int J Mol Sci"},{"key":"972_CR37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/17446651.2024.2310558","volume":"19","author":"TF Oliveira","year":"2024","unstructured":"Oliveira TF, Comim FV. Understanding hirsutism in PCOS. Expert Rev Endocrinol Metab. 2024;19:103\u201310.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"972_CR38","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaad.2018.08.062","volume":"80","author":"A Bienenfeld","year":"2019","unstructured":"Bienenfeld A, Azarchi S, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women. J Am Acad Dermatol. 2019;80:1497\u2013506.","journal-title":"J Am Acad Dermatol"},{"key":"972_CR39","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/j.2040-4603.2018.tb00043.x","volume":"8","author":"A Tchernof","year":"2018","unstructured":"Tchernof A, Brochu D, Maltais-Payette I, Mansour MF, Marchand GB, Carreau A, et al. Androgens and the regulation of adiposity and body fat distribution in humans. Compr Physiol. 2018;8:1253\u201390.","journal-title":"Compr Physiol"},{"key":"972_CR40","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1530\/EJE-17-0124","volume":"177","author":"L Schiffer","year":"2017","unstructured":"Schiffer L, Kempegowda P, Arlt W, O\u2019Reilly MW. Mechanisms in endocrinology: the sexually dimorphic role of androgens in human metabolic disease. Eur J Endocrinol. 2017;177:R125\u201343.","journal-title":"Eur J Endocrinol"},{"key":"972_CR41","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/molehr\/gat065","volume":"19","author":"M Lebbe","year":"2013","unstructured":"Lebbe M, Woodruff TK. Involvement of androgens in ovarian health and disease. Mol Hum Reprod. 2013;19:828\u201337.","journal-title":"Mol Hum Reprod"},{"key":"972_CR42","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1210\/en.2019-00101","volume":"160","author":"O Astapova","year":"2019","unstructured":"Astapova O, Minor BMN, Hammes SR. Physiological and pathological androgen actions in the ovary. Endocrinology. 2019;160:1166\u201374.","journal-title":"Endocrinology"},{"key":"972_CR43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-319-69535-8_4","volume":"1043","author":"EZ Drobnis","year":"2017","unstructured":"Drobnis EZ, Nangia AK. Exogenous androgens and male reproduction. Adv Exp Med Biol. 2017;1043:25\u201338.","journal-title":"Adv Exp Med Biol"},{"key":"972_CR44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12916-025-03901-w","volume":"23","author":"AS Pe\u00f1a","year":"2025","unstructured":"Pe\u00f1a AS, Witchel SF, Boivin J, Burgert TS, Ee C, Hoeger KM, et al. International evidence-based recommendations for polycystic ovary syndrome in adolescents. BMC Med. 2025;23:151.","journal-title":"BMC Med"},{"key":"972_CR45","doi-asserted-by":"crossref","first-page":"3572","DOI":"10.1210\/jc.2013-1770","volume":"98","author":"RL Rosenfield","year":"2013","unstructured":"Rosenfield RL. Clinical review: adolescent anovulation: maturational mechanisms and implications. J Clin Endocrinol Metab. 2013;98:3572\u201383.","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR46","volume":"12","author":"B Meczekalski","year":"2023","unstructured":"Meczekalski B, Niwczyk O, Kostrzak A, Maciejewska-Jeske M, Bala G, Szeliga A. PCOS in adolescents-ongoing riddles in diagnosis and treatment. J Clin Med. 2023;12:1221.","journal-title":"J Clin Med"},{"key":"972_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1471-0528.2009.02383.x","volume":"117","author":"CM Burt Solorzano","year":"2010","unstructured":"Burt Solorzano CM, McCartney CR, Blank SK, Knudsen KL, Marshall JC. Hyperandrogenaemia in adolescent girls: origins of abnormal gonadotropin-releasing hormone secretion. BJOG. 2010;117:143\u20139.","journal-title":"BJOG"},{"key":"972_CR48","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1590\/S0004-27302011000800013","volume":"55","author":"PM Merino","year":"2011","unstructured":"Merino PM, Codner E, Cassorla F. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence. Arq Bras Endocrinol Metabol. 2011;55:590\u20138.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"972_CR49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nrendo.2014.58","volume":"10","author":"L Ib\u00e1\u00f1ez","year":"2014","unstructured":"Ib\u00e1\u00f1ez L, Ong KK, L\u00f3pez-Bermejo A, Dunger DB, de Zegher F. Hyperinsulinaemic androgen excess in adolescent girls. Nat Rev Endocrinol. 2014;10:499\u2013508.","journal-title":"Nat Rev Endocrinol"},{"key":"972_CR50","doi-asserted-by":"publisher","DOI":"10.1159\/000542393","author":"AM Fulghesu","year":"2024","unstructured":"Fulghesu AM, Di Michele S, Zangaris I, Cordella M, Pittui E, Scalise G, et al. Clinical and ultrasound features of normocyclic non-hyperandrogenic adolescents in early gynecological life. Gynecol Obstet Invest. 2024. https:\/\/doi.org\/10.1159\/000542393.","journal-title":"Gynecol Obstet Invest"},{"key":"972_CR51","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jpag.2021.02.004","volume":"34","author":"AM Fulghesu","year":"2021","unstructured":"Fulghesu AM, Canu E, Casula L, Melis F, Gambineri A. Polycystic ovarian morphology in normocyclic non-hyperandrogenic adolescents. J Pediatr Adolesc Gynecol. 2021;34:610\u20136.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"972_CR52","first-page":"291","volume":"8","author":"P Tsikouras","year":"2015","unstructured":"Tsikouras P, Spyros L, Manav B, Zervoudis S, Poiana C, Nikolaos T, et al. Features of polycystic ovary syndrome in adolescence. J Med Life. 2015;8:291\u20136.","journal-title":"J Med Life"},{"key":"972_CR53","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1093\/ejendo\/lvae125","volume":"191","author":"ACH Neven","year":"2024","unstructured":"Neven ACH, Forslund M, Ranashinha S, Mousa A, Tay CT, Pe\u00f1a A, et al. Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis. Eur J Endocrinol. 2024;191:S15-27.","journal-title":"Eur J Endocrinol"},{"key":"972_CR54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1687-9856-2014-6","volume":"2014","author":"MI Hernandez","year":"2014","unstructured":"Hernandez MI, Castro A, Bacallao K, Avila A, Espinoza A, Trejo L, et al. Hormonal profile and androgen receptor study in prepubertal girls with hypertrichosis. Int J Pediatr Endocrinol. 2014;2014:6.","journal-title":"Int J Pediatr Endocrinol"},{"key":"972_CR55","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cen.12028","volume":"79","author":"MA Bredella","year":"2013","unstructured":"Bredella MA, McManus S, Misra M. Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome. Clin Endocrinol (Oxf). 2013;79:199\u2013203.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"972_CR56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/humupd\/dmp024","volume":"16","author":"BO Yildiz","year":"2010","unstructured":"Yildiz BO, Bolour S, Woods K, Moore A, Azziz R. Visually scoring hirsutism. Hum Reprod Update. 2010;16:51\u201364.","journal-title":"Hum Reprod Update"},{"key":"972_CR57","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/humrep\/der102","volume":"26","author":"M Hickey","year":"2011","unstructured":"Hickey M, Doherty DA, Atkinson H, Sloboda DM, Franks S, Norman RJ, et al. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod. 2011;26:1469\u201377.","journal-title":"Hum Reprod"},{"key":"972_CR58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/humrep\/deq303","volume":"26","author":"JJ Kim","year":"2011","unstructured":"Kim JJ, Chae SJ, Choi YM, Hwang SS, Hwang KR, Kim SM, et al. Assessment of hirsutism among Korean women: results of a randomly selected sample of women seeking pre-employment physical check-up. Hum Reprod. 2011;26:214\u201320.","journal-title":"Hum Reprod"},{"key":"972_CR59","doi-asserted-by":"crossref","first-page":"631","DOI":"10.5114\/ada.2018.77615","volume":"35","author":"BG Lumezi","year":"2018","unstructured":"Lumezi BG, Berisha VL, Pupovci HL, Go\u00e7i A, Hajrushi AB. Grading of hirsutism based on the Ferriman-Gallwey scoring system in Kosovar women. Adv Dermatol Allergol. 2018;35:631\u20135.","journal-title":"Adv Dermatol Allergol"},{"key":"972_CR60","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.fertnstert.2011.06.040","volume":"96","author":"X Zhao","year":"2011","unstructured":"Zhao X, Ni R, Mo Y, Huang J, Azziz R, Yang D. Defining hirsutism in Chinese women: a cross-sectional study. Fertil Steril. 2011;96:792\u20136.","journal-title":"Fertil Steril"},{"key":"972_CR61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/0974-2077.178536","volume":"9","author":"M Gupta","year":"2016","unstructured":"Gupta M, Mysore V. Classifications of patterned hair loss: a review. J Cutan Aesthet Surg. 2016;9:3\u201312.","journal-title":"J Cutan Aesthet Surg"},{"key":"972_CR62","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1097\/AOG.0000000000003475","volume":"134","author":"Screening and management of the hyperandrogenic adolescent","year":"2019","unstructured":"Screening and management of the hyperandrogenic adolescent. ACOG Committee opinion, number 789. Obstet Gynecol. 2019;134:e106\u201314.","journal-title":"Obstet Gynecol"},{"key":"972_CR63","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2147\/CLEP.S323744","volume":"13","author":"N Kirsten","year":"2021","unstructured":"Kirsten N, Mohr N, Alhumam A, Augustin M. Prevalence and associated diseases of seborrheic skin in adults. Clin Epidemiol. 2021;13:845\u201351.","journal-title":"Clin Epidemiol"},{"key":"972_CR64","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","volume":"14","author":"SS Lim","year":"2013","unstructured":"Lim SS, Norman RJ, Davies MJ, Moran LJ. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14:95\u2013109.","journal-title":"Obes Rev"},{"key":"972_CR65","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jpeds.2012.11.019","volume":"162","author":"AH Roe","year":"2013","unstructured":"Roe AH, Prochaska E, Smith M, Sammel M, Dokras A. Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J Pediatr. 2013;162:937\u201341.","journal-title":"J Pediatr"},{"key":"972_CR66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s13224-017-1035-y","volume":"68","author":"SR Rajiwade","year":"2018","unstructured":"Rajiwade SR, Sagili H, Soundravally R, Subitha L. Endocrine abnormalities in adolescents with menstrual disorders. J Obstet Gynaecol India. 2018;68:58\u201364.","journal-title":"J Obstet Gynaecol India"},{"key":"972_CR67","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/AOG.0000000000001215","volume":"126","author":"ACOG Committee Opinion No","year":"2015","unstructured":"ACOG Committee Opinion No. 651: menstruation in girls and adolescents: using the menstrual cycle as a vital sign. Obstet Gynecol. 2015;126:e143\u20136.","journal-title":"Obstet Gynecol"},{"key":"972_CR68","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1210\/jc.2012-3537","volume":"98","author":"A Gambineri","year":"2013","unstructured":"Gambineri A, Fanelli F, Prontera O, Repaci A, Di Dalmazi G, Zanotti L, et al. Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on Italian high-school students. J Clin Endocrinol Metab. 2013;98:1641\u201350.","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR69","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038647","volume":"103","author":"H Almhmoud","year":"2024","unstructured":"Almhmoud H, Alatassi L, Baddoura M, Sandouk J, Alkayali MZ, Najjar H, et al. Polycystic ovary syndrome and its multidimensional impacts on women\u2019s mental health: a narrative review. Medicine (Baltimore). 2024;103:e38647.","journal-title":"Medicine (Baltimore)"},{"key":"972_CR70","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Zhang J, Zheng X, Lu W, Guo J, Chen F, et al. Depression, anxiety and self-esteem in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2024;15:1399580.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"972_CR71","doi-asserted-by":"crossref","first-page":"3269618","DOI":"10.1155\/2018\/3269618","volume":"2018","author":"A Zachurzok","year":"2018","unstructured":"Zachurzok A, Pasztak-Opilka A, Forys-Dworniczak E, Drosdzol-Cop A, Gawlik A, Malecka-Tendera E. Are psychosocial consequences of obesity and hyperandrogenism present in adolescent girls with polycystic ovary syndrome? Int J Endocrinol. 2018;2018:3269618.","journal-title":"Int J Endocrinol"},{"key":"972_CR72","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2015.11612","volume":"314","author":"S Sam","year":"2015","unstructured":"Sam S, Ehrmann DA. Hormonal evaluation of hyperandrogenism. JAMA. 2015;314:2557\u20138.","journal-title":"JAMA"},{"key":"972_CR73","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.mcna.2021.06.008","volume":"105","author":"A Sharma","year":"2021","unstructured":"Sharma A, Welt CK. Practical approach to hyperandrogenism in women. Med Clin North Am. 2021;105:1099\u2013116.","journal-title":"Med Clin North Am"},{"key":"972_CR74","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.medcli.2018.11.019","volume":"152","author":"AE Ortiz-Flores","year":"2019","unstructured":"Ortiz-Flores AE, Luque-Ram\u00edrez M, Escobar-Morreale HF. Polycystic ovary syndrome in adult women. Med Clin (Barc). 2019;152:450\u20137 (in English, Spanish).","journal-title":"Med Clin (Barc)."},{"key":"972_CR75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00404-024-07897-1","volume":"311","author":"V Unfer","year":"2025","unstructured":"Unfer V, Lepore E, Forte G, Hern\u00e1ndez Mar\u00edn I, Wdowiak A, Pkhaladze L. Hyperandrogenism in polycystic ovary syndrome and adrenal hyperplasia: finding differences to make a specific diagnosis. Arch Gynecol Obstet. 2025;311:25\u201332.","journal-title":"Arch Gynecol Obstet"},{"key":"972_CR76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bpobgyn.2016.02.005","volume":"37","author":"RY Zhu","year":"2016","unstructured":"Zhu RY, Wong YC, Yong EL. Sonographic evaluation of polycystic ovaries. Best Pract Res Clin Obstet Gynaecol. 2016;37:25\u201337.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"972_CR77","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/09513590.2020.1770724","volume":"37","author":"S Ashraf","year":"2021","unstructured":"Ashraf S, Rasool SUA, Nabi M, Ganie MA, Jabeen F, Rashid F, et al. CYP17 gene polymorphic sequence variation is associated with hyperandrogenism in Kashmiri women with polycystic ovarian syndrome. Gynecol Endocrinol. 2021;37:230\u20134.","journal-title":"Gynecol Endocrinol"},{"key":"972_CR78","doi-asserted-by":"crossref","first-page":"e1082","DOI":"10.1542\/peds.2012-1726","volume":"131","author":"EM Urbina","year":"2013","unstructured":"Urbina EM, Khoury PR, McCoy CE, Dolan LM, Daniels SR, Kimball TR. Triglyceride to HDL-C ratio and increased arterial stiffness in children, adolescents, and young adults. Pediatrics. 2013;131:e1082\u201390.","journal-title":"Pediatrics"},{"key":"972_CR79","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3390\/biomedicines13020453","volume":"13","author":"S Di Michele","year":"2025","unstructured":"Di Michele S, Fulghesu AM, Pittui E, Cordella M, Sicilia G, Mandurino G, et al. Ultrasound assessment in polycystic ovary syndrome diagnosis: from origins to future perspectives-a comprehensive review. Biomedicines. 2025;13:453.","journal-title":"Biomedicines"},{"key":"972_CR80","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.fertnstert.2018.05.004","volume":"110","author":"HJ Teede","year":"2018","unstructured":"Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. International evidence-based guideline for the assessment and management of PCOS. Fertil Steril. 2018;110:364\u201379.","journal-title":"Fertil Steril"},{"key":"972_CR81","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mcna.2021.06.008","volume":"105","author":"A Sharma","year":"2021","unstructured":"Sharma A, Welt CK. Diagnostic strategies in severe hyperandrogenism. Med Clin North Am. 2021;105:19\u201333.","journal-title":"Med Clin North Am"},{"key":"972_CR82","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000326688","volume":"22","author":"S Catteau-Jonard","year":"2012","unstructured":"Catteau-Jonard S, Cortet-Rudelli C, Richard-Proust C, Dewailly D. Hyperandrogenism in adolescent girls. Endocr Dev. 2012;22:181\u201393.","journal-title":"Endocr Dev"},{"key":"972_CR83","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1515\/jpem-2016-0340","volume":"30","author":"MI Hernandez","year":"2017","unstructured":"Hernandez MI, L\u00f3pez P, Gaete X, Villarroel C, Cavada G, Avila A, et al. Hyperandrogenism in adolescent girls: relationship with the somatotrophic axis. J Pediatr Endocrinol Metab. 2017;30:561\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"972_CR84","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa003","volume":"41","author":"KA Mason","year":"2020","unstructured":"Mason KA, Schoelwer MJ, Rogol AD. Androgens during infancy, childhood, and adolescence: physiology and use in clinical practice. Endocr Rev. 2020;41:bnaa003.","journal-title":"Endocr Rev"},{"key":"972_CR85","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1159\/000526722","volume":"95","author":"SF Witchel","year":"2022","unstructured":"Witchel SF, Azziz R, Oberfield SE. History of polycystic ovary syndrome, premature adrenarche, and hyperandrogenism in pediatric endocrinology. Horm Res Paediatr. 2022;95:557\u201367.","journal-title":"Horm Res Paediatr"},{"key":"972_CR86","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/jpc.13821","volume":"54","author":"AS Pe\u00f1a","year":"2018","unstructured":"Pe\u00f1a AS, Metz M. What is adolescent polycystic ovary syndrome? J Paediatr Child Health. 2018;54:351\u20135.","journal-title":"J Paediatr Child Health"},{"key":"972_CR87","first-page":"36","volume":"2020","author":"MGD Cunha","year":"1992","unstructured":"Cunha MGD, Moraes C, Cebrian G, da Silva RF, Reple SIF, Filho C, et al. Dosages of androgenic hormones in adolescent patients with severe acne. Rev Assoc Med Bras. 1992;2020:36\u201341.","journal-title":"Rev Assoc Med Bras"},{"key":"972_CR88","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000481532","volume":"88","author":"PM Merino","year":"2017","unstructured":"Merino PM, Villarroel C, Jesam C, L\u00f3pez P, Codner E. New diagnostic criteria of polycystic ovarian morphology for adolescents: impact on prevalence and hormonal profile. Horm Res Paediatr. 2017;88:401\u20137.","journal-title":"Horm Res Paediatr"},{"key":"972_CR89","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/humupd\/dmad027","volume":"30","author":"J Pea","year":"2024","unstructured":"Pea J, Bryan J, Wan C, Oldfield AL, Ganga K, Carter FE, et al. Ultrasonographic criteria in the diagnosis of polycystic ovary syndrome: a systematic review and diagnostic meta-analysis. Hum Reprod Update. 2024;30:109\u201330.","journal-title":"Hum Reprod Update"},{"key":"972_CR90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMcp1514916","volume":"375","author":"CR McCartney","year":"2016","unstructured":"McCartney CR, Marshall JC. Polycystic ovary syndrome. N Engl J Med. 2016;375:54\u201364.","journal-title":"N Engl J Med"},{"key":"972_CR91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1017\/S0954422418000136","volume":"31","author":"L Barrea","year":"2018","unstructured":"Barrea L, Marzullo P, Muscogiuri G, Somma CD, Scacchi M, Orio F, et al. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Nutr Res Rev. 2018;31:291\u2013301.","journal-title":"Nutr Res Rev"},{"key":"972_CR92","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12978-024-01758-5","volume":"21","author":"AE Juh\u00e1sz","year":"2024","unstructured":"Juh\u00e1sz AE, Stubnya MP, Teutsch B, Gede N, Hegyi P, Nyir\u00e1dy P, et al. Ranking the dietary interventions by their effectiveness in the management of polycystic ovary syndrome: a systematic review and network meta-analysis. Reprod Health. 2024;21:28.","journal-title":"Reprod Health"},{"key":"972_CR93","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1542\/peds.2015-1430","volume":"136","author":"RL Rosenfield","year":"2015","unstructured":"Rosenfield RL. The diagnosis of polycystic ovary syndrome in adolescents. Pediatrics. 2015;136:1154\u201365.","journal-title":"Pediatrics"},{"key":"972_CR94","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.fertnstert.2016.10.027","volume":"106","author":"A Dokras","year":"2016","unstructured":"Dokras A. Noncontraceptive use of oral combined hormonal contraceptives in polycystic ovary syndrome-risks versus benefits. Fertil Steril. 2016;106:1572\u20139.","journal-title":"Fertil Steril"},{"key":"972_CR95","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/jc.2014-3196","volume":"100","author":"BO Yildiz","year":"2015","unstructured":"Yildiz BO. Approach to the patient: contraception in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100:794\u2013802.","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR96","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1001\/jamapediatrics.2015.4866","volume":"170","author":"EL Fields","year":"2016","unstructured":"Fields EL, Trent ME. Treatment considerations for the cardiometabolic signs of polycystic ovary syndrome: a review of the literature since the 2013 Endocrine Society clinical practice guidelines. JAMA Pediatr. 2016;170:502\u20137.","journal-title":"JAMA Pediatr"},{"key":"972_CR97","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1089\/chi.2013.0120","volume":"10","author":"E Estrada","year":"2014","unstructured":"Estrada E, Eneli I, Hampl S, Mietus-Snyder M, Mirza N, Rhodes E, et al. Children\u2019s Hospital Association consensus statements for comorbidities of childhood obesity. Child Obes. 2014;10:304\u201317.","journal-title":"Child Obes"},{"key":"972_CR98","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-4089","volume":"137","author":"RA Al Khalifah","year":"2016","unstructured":"Al Khalifah RA, Florez ID, Dennis B, Thabane L, Bassilious E. Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis. Pediatrics. 2016;137:e20154089.","journal-title":"Pediatrics"},{"key":"972_CR99","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.jogc.2017.05.022","volume":"39","author":"K Liu","year":"2017","unstructured":"Liu K, Motan T, Claman P. No. 350\u2013hirsutism: evaluation and treatment. J Obstet Gynaecol Can. 2017;39:1054\u201368.","journal-title":"J Obstet Gynaecol Can"},{"key":"972_CR100","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14680","volume":"34","author":"R Dhurat","year":"2021","unstructured":"Dhurat R, Shukla D, Lim RK, Wambier CG, Goren A. Spironolactone in adolescent acne vulgaris. Dermatol Ther. 2021;34:e14680.","journal-title":"Dermatol Ther"},{"key":"972_CR101","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clindermatol.2016.10.009","volume":"35","author":"B Barros","year":"2017","unstructured":"Barros B, Thiboutot D. Hormonal therapies for acne. Clin Dermatol. 2017;35:168\u201372.","journal-title":"Clin Dermatol"},{"issue":"Suppl 1","key":"972_CR102","first-page":"S60","volume":"8","author":"CC Zouboulis","year":"2010","unstructured":"Zouboulis CC, Rabe T. Hormonal antiandrogens in acne treatment. J Dtsch Dermatol Ges. 2010;8(Suppl 1):S60-74 (in German).","journal-title":"J Dtsch Dermatol Ges"},{"key":"972_CR103","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jaad.2018.08.061","volume":"80","author":"S Azarchi","year":"2019","unstructured":"Azarchi S, Bienenfeld A, Lo Sicco K, Marchbein S, Shapiro J, Nagler AR. Androgens in women: hormone-modulating therapies for skin disease. J Am Acad Dermatol. 2019;80:1509\u201321.","journal-title":"J Am Acad Dermatol"},{"key":"972_CR104","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1080\/09513590.2017.1397114","volume":"34","author":"AM Fulghesu","year":"2018","unstructured":"Fulghesu AM, Melis F, Murru G, Canu E, Melis GB. Very low dose of flutamide in the treatment of hyperandrogenism. Gynecol Endocrinol. 2018;34:394\u20138.","journal-title":"Gynecol Endocrinol"},{"key":"972_CR105","volume":"151","author":"E Sarah","year":"2023","unstructured":"Sarah E, Sandra G, Asheley C, Armstrong SC, Barlow SE, Bolling CF, et al. Clinical practice guideline for the evaluation and treatment of children and adolescents with obesity. Pediatrics. 2023;151:e2022060640.","journal-title":"Pediatrics"},{"key":"972_CR106","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1007\/s12325-025-03251-2","volume":"42","author":"SG Vitale","year":"2025","unstructured":"Vitale SG, Di Michele S, Tassi A, Succu C, Angioni S, Fulghesu AM. Sustained metabolic improvements with low-dose metformin combined with oral contraceptives in female adolescents with PCOS: a single-center retrospective cohort study. Adv Ther. 2025;42:3762\u201373.","journal-title":"Adv Ther"},{"key":"972_CR107","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1210\/jc.2014-4290","volume":"100","author":"RL Rosenfield","year":"2015","unstructured":"Rosenfield RL, Ehrmann DA, Littlejohn EE. Adolescent polycystic ovary syndrome due to functional ovarian hyperandrogenism persists into adulthood. J Clin Endocrinol Metab. 2015;100:1537\u201343.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"972_CR108","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1210\/clinem\/dgae696","volume":"110","author":"H Engberg","year":"2025","unstructured":"Engberg H, Nordenstr\u00f6m A, Hirschberg AL. Clinical manifestations and challenges in adolescent and adult females with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab. 2025;110(Suppl 1):S37\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"972_CR109","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3390\/diagnostics12081931","volume":"12","author":"AS Pe\u00f1a","year":"2022","unstructured":"Pe\u00f1a AS, Witchel S, Codner E. Criteria for diagnosis of polycystic ovary syndrome during adolescence: literature review. Diagnostics. 2022;12:1931.","journal-title":"Diagnostics"},{"key":"972_CR110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1055\/s-0039-1693530","volume":"41","author":"JM Soares-Jr","year":"2019","unstructured":"Soares-Jr JM, S\u00e1 MFS, Baracat EC. New criteria for the clinical diagnosis of hyperandrogenism in polycystic ovarian syndrome and the risk of overdiagnosis. Rev Bras Ginecol Obstet. 2019;41:361\u20132.","journal-title":"Rev Bras Ginecol Obstet"},{"key":"972_CR111","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.bpobgyn.2016.05.003","volume":"37","author":"D Lizneva","year":"2016","unstructured":"Lizneva D, Gavrilova-Jordan L, Walker W, Azziz R. Androgen excess: investigations and management. Best Pract Res Clin Obstet Gynaecol. 2016;37:98\u2013118.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"972_CR112","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.mce.2013.01.005","volume":"373","author":"RM Williams","year":"2013","unstructured":"Williams RM, Ong KK, Dunger DB. Polycystic ovarian syndrome during puberty and adolescence. Mol Cell Endocrinol. 2013;373:61\u20137.","journal-title":"Mol Cell Endocrinol"},{"key":"972_CR113","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/humrep\/deu200","volume":"29","author":"S West","year":"2014","unstructured":"West S, Laitinen J, Kauppila A, Anttila L, Aittom\u00e4ki K, Bloigu A, et al. Irregular menstruation and hyperandrogenaemia in adolescence are associated with polycystic ovary syndrome and infertility in later life: Northern Finland Birth Cohort 1986 study. Hum Reprod. 2014;29:2339\u201351.","journal-title":"Hum Reprod"},{"key":"972_CR114","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cen.14967","volume":"101","author":"R Pofi","year":"2024","unstructured":"Pofi R, Ji X, Krone NP, Tomlinson JW. Long-term health consequences of congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 2024;101:318\u201331.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"972_CR115","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/archdischild-2016-311910","volume":"102","author":"CF Mooij","year":"2017","unstructured":"Mooij CF, Webb EA, van der Claahsen Grinten HL, Krone N. Cardiovascular health, growth and gonadal function in children and adolescents with congenital adrenal hyperplasia. Arch Dis Child. 2017;102:578\u201384.","journal-title":"Arch Dis Child"},{"key":"972_CR116","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s12098-023-04678-7","volume":"90","author":"V Yadav","year":"2023","unstructured":"Yadav V, Sharma Y. Hyperandrogenism. Indian J Pediatr. 2023;90:1018\u201324.","journal-title":"Indian J Pediatr"},{"key":"972_CR117","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","volume":"97","author":"BCJM Fauser","year":"2012","unstructured":"Fauser BCJM, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R, et al. Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. Fertil Steril. 2012;97:28\u201338.e25.","journal-title":"Fertil Steril"},{"key":"972_CR118","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1161\/CIRCRESAHA.121.319916","volume":"130","author":"ES Lau","year":"2022","unstructured":"Lau ES, Binek A, Parker SJ, Shah SH, Zanni MV, Van Eyk JE, et al. Sexual dimorphism in cardiovascular biomarkers: clinical and research implications. Circ Res. 2022;130:578\u201392.","journal-title":"Circ Res"},{"key":"972_CR119","doi-asserted-by":"crossref","first-page":"H279","DOI":"10.1152\/ajpheart.00462.2022","volume":"324","author":"DH Chang","year":"2023","unstructured":"Chang DH, Dumanski SM, Ahmed SB. Female sex-specific considerations to improve rigor and reproducibility in cardiovascular research. Am J Physiol Heart Circ Physiol. 2023;324:H279\u201387.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"972_CR120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/jora.12402","volume":"29","author":"J Deardorff","year":"2019","unstructured":"Deardorff J, Hoyt LT, Carter R, Shirtcliff EA. Next steps in puberty research: broadening the lens toward understudied populations. J Res Adolesc. 2019;29:133\u201354.","journal-title":"J Res Adolesc"},{"key":"972_CR121","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1530\/EJE-10-0693","volume":"163","author":"SC Mueller","year":"2010","unstructured":"Mueller SC, Ng P, Sinaii N, Leschek EW, Green-Golan L, VanRyzin C, et al. Psychiatric characterization of children with genetic causes of hyperandrogenism. Eur J Endocrinol. 2010;163:801\u201310.","journal-title":"Eur J Endocrinol"},{"key":"972_CR122","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1297\/cpe.2022-0010","volume":"31","author":"Z Donbalo\u011flu","year":"2022","unstructured":"Donbalo\u011flu Z, Tuhan H, \u00c7oban \u00d6G, K\u0131z\u0131lay D\u00d6, \u0130smailo\u011flu E, \u00d6nder A, et al. Hyperandrogenism correlates with psychological symptoms in adolescents with polycystic ovary syndrome. Clin Pediatr Endocrinol. 2022;31:68\u201376.","journal-title":"Clin Pediatr Endocrinol"},{"key":"972_CR123","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jpag.2019.07.008","volume":"32","author":"\u00d6G \u00c7oban","year":"2019","unstructured":"\u00c7oban \u00d6G, Tulac\u0131 \u00d6D, Adan\u0131r AS, \u00d6nder A. Psychiatric disorders, self-esteem, and quality of life in adolescents with polycystic ovary syndrome. J Pediatr Adolesc Gynecol. 2019;32:600\u20134.","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"972_CR124","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000479371","volume":"88","author":"L Ib\u00e1\u00f1ez","year":"2017","unstructured":"Ib\u00e1\u00f1ez L, Oberfield SE, Witchel S, Auchus RJ, Chang RJ, Codner E, et al. An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome in adolescence. Horm Res Paediatr. 2017;88:371\u201395.","journal-title":"Horm Res Paediatr"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-025-00972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12519-025-00972-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-025-00972-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T19:05:58Z","timestamp":1761937558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12519-025-00972-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":124,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["972"],"URL":"https:\/\/doi.org\/10.1007\/s12519-025-00972-w","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No financial or non-financial benefits have been received or will be received from any party related directly or indirectly to the subject of this article. The authors have no conflict of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}